Sandoz US News
Sandoz launches first generic version of ATACAND®
Sandoz today announced the US Food and Drug Administration (FDA) approval and US launch of candesartan cilexetil tablets, the first generic version of ATACAND®.
- Read more
- May 22, 2013
Sandoz Multimedia
Visit our multimedia gallery to learn about Sandoz.
Product Catalog
Use our Product Catalog tool to search our database for information regarding a specific Sandoz product in the US.
Quick Links
Click below for important links.
Sandoz Careers
Our people are our greatest resource. We are always looking for new colleagues to share in our passion and commitment to making the world a healthier place.
-
Sandoz in the US
Sandoz in the US
A Healthy Decision
Sandoz is a world leader in generic pharmaceuticals, providing access to a wide array of high-quality, affordable medicines. In the US, Sandoz markets more than 200 different generic drugs, including enoxaparin sodium injection, the first generic version of Lovenox®, and Omnitrope®, the groundbreaking follow-on biologic. Our 2,300 US associates are proud to make Sandoz a "healthy decision." Learn more about Sandoz in the US
-
Quality
Quality
Everyone Can Afford
As part of the Novartis group, we believe that superior quality is the key to our long-term success. Our state-of-the-art technologies, decades of experience, and rigorous across-the-board quality standards all contribute to our broad portfolio of premium quality generic medicines. Learn more about our Quality Standards
-
Complex Generics
Differentiation
Shaping the Future of Healthcare
We use innovation and expertise to go beyond standard generics and develop even the most complex medicines, which add value to patient healthcare – from generic injectables and ophthalmics to biosimilars and respiratory. Driving patient access to cost-effective treatment is how we are shaping the future of healthcare. Learn more about our Products
-
Biosimilars
Pioneering Biosimilars
The Market of the Future
Sandoz was the first company to develop and market follow-on versions of highly-complex biopharmaceuticals. Today, we are the undisputed global leader in this segment and have an industry-leading pipeline that will make essential biologics more affordable for all. Discover Sandoz Biosimilars
